FB deal puts RIL on course to be debt-free next year; Reliance Retail biggest gainer from WhatsApp, JioMart arrangement.
The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality drug payoffs.
With little clarity on the demand outlook, investors should wait out the next couple of quarters rather than rush in to catch a falling knife, says Ram Prasad Sahu.
Given the school break, this is the peak travel season and companies catering to the 'friends and family' segment are expected to gain.
From Dabur to HUL, here are 10 stocks with significant rural exposure in the auto, agri-chemical and fast moving consumer goods sectors, which should see an uptick in sales growth.
Price cuts post the November GST rate rationalisation helped improve volume growth for HUL, what pegged back sales for ITC is adverse social media rumours against Aashirvaad atta, its single-largest FMCG brand.
From MRF to Shree Cement: 23 companies which delivered 30% CAGR in 15 years.
Over-expansion, bad management, and multiple allegations irreparably taint Malvinder and Shivinder Singh
Street may be ignoring TCS headwinds as the stock's peak valuation doesn't seem justified by BFSI weakness, likely higher US tax rates and stronger rupee, reports Ram Prasad Sahu.
In the quarter ended September 30, the Pirojsha Godrej-led firm recorded Rs 492 crore net sales, up 49% year-on-year
What stocks will gain from a normal monsoon?
Falling revenues, increased capex, and first full year of spectrum debt may make things worse
Revenues of Airtel and Idea have been hit by falling realisation and analysts said margins would be affected by higher costs.
Ambani said, in the telecom space, the focus will be on debt reduction, and the virtual merger did away with the need for major capex and will help towards this
Almost a third of the company's capex was stuck in this project
Godrej Properties, is on the horizon as it unlocks value in its high-value Bandra-Kurla Complex (BKC) project.
Given its network and fleet, it has garnered the highest share of passenger growth.
The reason is believed to be a 19% increase in interest cost.
Brokerages have cut the company's FY16 earnings estimates between 16% and 29% with target prices too coming down to the Rs 700-800 band
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances